Serum Institute gets DCGI nod for clinical trials of Oxford vax

Mid-Day

03 Aug 2020 0 shares 1 views

Serum Institute gets DCGI nod for clinical trials of Oxford vax

Serum Institute gets DCGI nod for clinical trials of Oxford vax

Mid-Day

Published 03 Aug 2020

The Drugs Controller General of India (DCGI) has given approval to Pune's Serum Institute of India (SII) to conduct clinical trials of Oxford University-Astra Zeneca COVID-19 vaccine in India.

The SII received approval by the India's top drug regulator on Sunday after a thorough evaluation based on the recommendations of the...

You might like

Related news coverage

Phase II trial of Oxford COVID-19 vaccine candidate to begin in PGI Chandigarh

Mid-Day 27 Aug 2020

The Post Graduate Institute of Medical Education and Research (PGIMER) in Chandigarh will be beginning the Phase II trial of oxford..

COVID-19 vaccine: Happy to be part of noble, global effort, says Pune trial volunteer
Mid-Day 27 Aug 2020
Phase 2 trial of Oxford COVID-19 vaccine candidate to begin today
Mid-Day 25 Aug 2020
ICMR developing portal for information on COVID-19 vaccine
Mid-Day 23 Aug 2020
COVID-19: India to have coronavirus vaccine by 2020 end, says Harsh Vardhan
Mid-Day 23 Aug 2020

Advertisement

More coverage

Will the superfast 'Sputnik V' vaccine put citizens at risk?

Mid-Day 19 Aug 2020

With over 175 *COVID-19* vaccines currently in different stages of development, the entire human race is hoping that eventually one..

Post-Covid complications a new dimension, have to be aware: Niti Aayog member
Mid-Day 19 Aug 2020
COVID-19 vaccine candidate to enter phase-3 human trial: Health Ministry
Mid-Day 18 Aug 2020
COVID-19 cases haven't yet peaked or even plateaued: AIIMS Director
Mid-Day 12 Aug 2020
Expert panel to meet tomorrow, decide priority of who gets COVID-19 vaccine first
Mid-Day 11 Aug 2020